Sector ratings Sanofi

Equities

Market Closed - Euronext Paris Other stock markets 16:55:00 18/11/2025 GMT			5-day change	1st Jan Change
87.58 ^EUR	-2.57%		+0.89%	-6.57%

11-18	Gan & Lee Pharmaceuticals Europe GmbH Announces Committee for Medicinal Products for Human Use of the European Medicines Agency Recommends the Approval of Insulin Glargine Injection	CI
11-18	US FDA approves Arrowhead's genetic disorder drug	RE

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
SANOFI	127B		A
ELI LILLY AND COMPANY	915B		A
JOHNSON & JOHNSON	481B		BBB
ABBVIE INC.	414B		AA
ROCHE HOLDING AG	310B		AA
ASTRAZENECA PLC	278B		A
NOVARTIS AG	255B		AAA
MERCK & CO., INC.	230B		A
NOVO NORDISK A/S	216B		A
AMGEN INC.	184B		A
GILEAD SCIENCES, INC.	154B		AAA
PFIZER INC.	143B		BBB
VERTEX PHARMACEUTICALS INCORPORATED	110B		AA
BRISTOL-MYERS SQUIBB COMPANY	95.29B		A
GSK PLC	95.24B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	90.2B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
ALNYLAM PHARMACEUTICALS, INC.	60.84B		AA	-
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	57.72B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	44.51B		AA
Average	216.14B		AA
Weighted average by Cap.			AA